The Labors Of Califf
The US FDA Commissioner nominee Robert Califf has so far promised to revamp FDA’s opioids policy, stay away from industry after leaving the agency, and clean up Accelerated Approval in 30 days. What other tasks will Democratic Senators demand before granting him confirmation?
You may also be interested in...
Final Senate vote on Robert Califf’s nomination to lead the US Food and Drug Administration is expected 15 February after Califf narrowly squeaked through a procedural vote. The final vote is expected to be even tighter.
The unexpectedly tight fight to get Robert Califf confirmed as FDA commissioner is giving lawmakers additional leverage to extract commitments. However, the Senate Finance Chair may be overestimating FDA’s ability to swiftly pull accelerated approvals without new legislation.
The wait for a permanent head of the FDA is continuing into the second year of the Biden Administration. One message is coming through loud and clear: the agency is clearly not a top priority for the White House ... and that might just be a good thing.